“Modulation of Glycemic, Lipid, and HepatorenalBiomarkers by Silymarin Supplementation inType 2 Diabetes Mellitus”, Rev Diabet Stud, vol. 21, no. 1, May 2025, doi: 10.1900/1z2dn188.